Eukaryotic Cell, January 2007, p. 48-59, Vol. 6, No. 1
1535-9778/07/$08.00+0 doi:10.1128/EC.00318-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.
Vesicular Polysaccharide Export in Cryptococcus neoformans Is a Eukaryotic Solution to the Problem of Fungal Trans-Cell Wall Transport
Marcio L. Rodrigues,1,
Leonardo Nimrichter,1,
Débora L. Oliveira,1,
Susana Frases,2
Kildare Miranda,3
Oscar Zaragoza,2,
Mauricio Alvarez,2
Antonio Nakouzi,2
Marta Feldmesser,2,4 and
Arturo Casadevall2,4*
Laboratório de Estudos Integrados em Bioquímica Microbiana, Instituto de Microbiologia Professor Paulo de Góes, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941590, Brazil,1
Department of Microbiology and Immunology,2
and Division of Infectious Diseases,4
of the Department of Medicine, Albert Einstein College of Medicine, 1300 Morris Park Ave., Bronx, New York 10461; and Laboratório de Ultraestrutura Celular Hertha Meyer, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941590, Brazil3
Received 6 October 2006/
Accepted 6 November 2006
The mechanisms by which macromolecules are transported through the cell wall of fungi are not known. A central question in the biology of Cryptococcus neoformans, the causative agent of cryptococcosis, is the mechanism by which capsular polysaccharide synthesized inside the cell is exported to the extracellular environment for capsule assembly and release. We demonstrate that C. neoformans produces extracellular vesicles during in vitro growth and animal infection. Vesicular compartments, which are transferred to the extracellular space by cell wall passage, contain glucuronoxylomannan (GXM), a component of the cryptococcal capsule, and key lipids, such as glucosylceramide and sterols. A correlation between GXM-containing vesicles and capsule expression was observed. The results imply a novel mechanism for the release of the major virulence factor of C. neoformans whereby polysaccharide packaged in lipid vesicles crosses the cell wall and the capsule network to reach the extracellular environment.
* Corresponding author. Mailing address: Department of Microbiology and Immunology, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461. Phone: (718) 430-2215. Fax: (718) 430-8968. E-mail: casadeva{at}aecom.yu.edu.
Published ahead of print on 17 November 2006.
M.L.R., L.N., and D.L.O. contributed equally to this work.
Present address: Servicio de Micología, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Ctra Majadahonda-Pozuelo km 2, 28220 Majadahonda, Madrid, Spain.
Eukaryotic Cell, January 2007, p. 48-59, Vol. 6, No. 1
1535-9778/07/$08.00+0 doi:10.1128/EC.00318-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Rodrigues, M. L., Alvarez, M., Fonseca, F. L., Casadevall, A.
(2008). Binding of the Wheat Germ Lectin to Cryptococcus neoformans Suggests an Association of Chitinlike Structures with Yeast Budding and Capsular Glucuronoxylomannan. Eukaryot Cell
7: 602-609
[Abstract]
[Full Text]
-
Yoneda, A., Doering, T. L.
(2008). Regulation of Cryptococcus neoformans Capsule Size Is Mediated at the Polymer Level. Eukaryot Cell
7: 546-549
[Abstract]
[Full Text]
-
Rodrigues, M. L., Nakayasu, E. S., Oliveira, D. L., Nimrichter, L., Nosanchuk, J. D., Almeida, I. C., Casadevall, A.
(2008). Extracellular Vesicles Produced by Cryptococcus neoformans Contain Protein Components Associated with Virulence. Eukaryot Cell
7: 58-67
[Abstract]
[Full Text]
-
Siafakas, A. R., Sorrell, T. C., Wright, L. C., Wilson, C., Larsen, M., Boadle, R., Williamson, P. R., Djordjevic, J. T.
(2007). Cell Wall-linked Cryptococcal Phospholipase B1 Is a Source of Secreted Enzyme and a Determinant of Cell Wall Integrity. J. Biol. Chem.
282: 37508-37514
[Abstract]
[Full Text]
-
Rachini, A., Pietrella, D., Lupo, P., Torosantucci, A., Chiani, P., Bromuro, C., Proietti, C., Bistoni, F., Cassone, A., Vecchiarelli, A.
(2007). An Anti-{beta}-Glucan Monoclonal Antibody Inhibits Growth and Capsule Formation of Cryptococcus neoformans In Vitro and Exerts Therapeutic, Anticryptococcal Activity In Vivo. Infect. Immun.
75: 5085-5094
[Abstract]
[Full Text]
-
Rodrigues, M. L., Shi, L., Barreto-Bergter, E., Nimrichter, L., Farias, S. E., Rodrigues, E. G., Travassos, L. R., Nosanchuk, J. D.
(2007). Monoclonal Antibody to Fungal Glucosylceramide Protects Mice against Lethal Cryptococcus neoformans Infection. CVI
14: 1372-1376
[Abstract]
[Full Text]
-
Rhome, R., McQuiston, T., Kechichian, T., Bielawska, A., Hennig, M., Drago, M., Morace, G., Luberto, C., Del Poeta, M.
(2007). Biosynthesis and Immunogenicity of Glucosylceramide in Cryptococcus neoformans and Other Human Pathogens. Eukaryot Cell
6: 1715-1726
[Full Text]
-
Nimrichter, L., Frases, S., Cinelli, L. P., Viana, N. B., Nakouzi, A., Travassos, L. R., Casadevall, A., Rodrigues, M. L.
(2007). Self-Aggregation of Cryptococcus neoformans Capsular Glucuronoxylomannan Is Dependent on Divalent Cations. Eukaryot Cell
6: 1400-1410
[Abstract]
[Full Text]
-
McFadden, D. C., Fries, B. C., Wang, F., Casadevall, A.
(2007). Capsule Structural Heterogeneity and Antigenic Variation in Cryptococcus neoformans. Eukaryot Cell
6: 1464-1473
[Abstract]
[Full Text]
Copyright © 2007 by the American Society for Microbiology.